Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 6 |
GO:0032991 | protein-containing complex | 1 | 6 |
GO:0140513 | nuclear protein-containing complex | 2 | 6 |
GO:1990904 | ribonucleoprotein complex | 2 | 6 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005684 | U2-type spliceosomal complex | 4 | 1 |
GO:0005686 | U2 snRNP | 5 | 1 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 1 |
GO:0071004 | U2-type prespliceosome | 5 | 1 |
GO:0071010 | prespliceosome | 4 | 1 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 1 |
GO:0097525 | spliceosomal snRNP complex | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0120114 | Sm-like protein family complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A4HA73
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 6 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 6 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 6 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006396 | RNA processing | 6 | 7 |
GO:0006397 | mRNA processing | 7 | 6 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0008380 | RNA splicing | 7 | 6 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016070 | RNA metabolic process | 5 | 7 |
GO:0016071 | mRNA metabolic process | 6 | 6 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0045292 | mRNA cis splicing, via spliceosome | 9 | 6 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0090304 | nucleic acid metabolic process | 4 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003723 | RNA binding | 4 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.613 |
CLV_PCSK_KEX2_1 | 248 | 250 | PF00082 | 0.635 |
CLV_PCSK_PC1ET2_1 | 248 | 250 | PF00082 | 0.635 |
DOC_USP7_MATH_1 | 171 | 175 | PF00917 | 0.728 |
DOC_USP7_MATH_1 | 188 | 192 | PF00917 | 0.552 |
DOC_USP7_MATH_1 | 26 | 30 | PF00917 | 0.536 |
LIG_14-3-3_CanoR_1 | 8 | 18 | PF00244 | 0.511 |
LIG_FHA_1 | 157 | 163 | PF00498 | 0.706 |
LIG_FHA_1 | 26 | 32 | PF00498 | 0.753 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.663 |
LIG_IBAR_NPY_1 | 74 | 76 | PF08397 | 0.619 |
LIG_LIR_Gen_1 | 12 | 21 | PF02991 | 0.510 |
LIG_LIR_Gen_1 | 232 | 239 | PF02991 | 0.659 |
LIG_LIR_Nem_3 | 12 | 17 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 135 | 141 | PF02991 | 0.699 |
LIG_LIR_Nem_3 | 173 | 179 | PF02991 | 0.518 |
LIG_LIR_Nem_3 | 232 | 238 | PF02991 | 0.659 |
LIG_PCNA_yPIPBox_3 | 42 | 50 | PF02747 | 0.411 |
LIG_PTB_Apo_2 | 71 | 78 | PF02174 | 0.619 |
LIG_SH2_CRK | 90 | 94 | PF00017 | 0.546 |
LIG_SH2_NCK_1 | 21 | 25 | PF00017 | 0.776 |
LIG_SH2_SRC | 203 | 206 | PF00017 | 0.782 |
LIG_SH2_STAP1 | 176 | 180 | PF00017 | 0.556 |
LIG_SH2_STAP1 | 235 | 239 | PF00017 | 0.644 |
LIG_SH2_STAT3 | 145 | 148 | PF00017 | 0.670 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.633 |
LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.546 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.546 |
LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.546 |
LIG_SH2_STAT5 | 92 | 95 | PF00017 | 0.546 |
MOD_CK2_1 | 147 | 153 | PF00069 | 0.764 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.781 |
MOD_GlcNHglycan | 164 | 168 | PF01048 | 0.554 |
MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.782 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.618 |
MOD_GlcNHglycan | 204 | 208 | PF01048 | 0.781 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.690 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.524 |
MOD_N-GLC_1 | 156 | 161 | PF02516 | 0.537 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.546 |
MOD_PKA_2 | 101 | 107 | PF00069 | 0.743 |
MOD_Plk_1 | 26 | 32 | PF00069 | 0.539 |
MOD_Plk_4 | 26 | 32 | PF00069 | 0.569 |
TRG_ENDOCYTIC_2 | 14 | 17 | PF00928 | 0.514 |
TRG_ENDOCYTIC_2 | 235 | 238 | PF00928 | 0.640 |
TRG_ENDOCYTIC_2 | 76 | 79 | PF00928 | 0.546 |
TRG_ENDOCYTIC_2 | 90 | 93 | PF00928 | 0.504 |
TRG_ER_diArg_1 | 247 | 250 | PF00400 | 0.731 |
TRG_ER_diArg_1 | 67 | 70 | PF00400 | 0.546 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PET4 | Leptomonas seymouri | 53% | 100% |
A0A3S7WVH7 | Leishmania donovani | 79% | 100% |
A4HYE5 | Leishmania infantum | 80% | 100% |
E9AS78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 78% | 100% |
Q4QD88 | Leishmania major | 80% | 97% |